IP Library Granted Patent US 10,188,534
Granted Patent B2
US 10,188,534 · App. 11/939,627 · Granted Jan 29, 2019

Stent having reduced passage of emboli and stent delivery system

Inventors: Doug Molland (Excelsior, MN); Jianlu Ma (Maple Grove, MN); Joe Tatalovich (St. Louis Park, MN); Jeff Vogel (Brooklyn Park, MN); Josh Dudney (Minneapolis, MN); Mark Vandlik (Shorewood, MN); Richard Kusleika (Eden Prairie, MN)
Assignee: Covidien LP
A61F2/90A61F2/91A61F2210/0057A61F2210/0076A61F2220/0041A61F2250/0023A61F2250/0048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,188,534
App. No.
11/939,627
Granted
Jan 29, 2019
Kind
B2
Abstract

A stent for reducing the passage of emboli into body lumen once deployed includes a structural portion and a barrier portion. The structural portion, when expanded in a conduit, provides sufficient strength to maintain an open lumen in the conduit. The barrier portion reduces migration of emboli from the wall of the conduit through the structural portion and into the lumen. Stent delivery systems capable of delivering and deploying the stent are disclosed.

Claims (10)

1. An expandable tubular stent for implantation in a body lumen comprising:

a structural portion extending along an axis being radially expandable thereabout and having a first expanded percentage open area, the structure portion including a plurality of struts; and

a barrier portion affixed to the structural portion and having a second expanded percentage open area, the barrier portion including a plurality of pores extending therethrough, the barrier portion being at least partially made of metal;

the stent having a composite expanded percentage open area within a range of 65% to 95%, wherein the composite expanded percentage open area is calculated by finding a difference between an area of the pores of the expanded barrier portion and an area of said pores occluded by the struts of the expanded structural portion, and dividing said difference by surface area of the expanded stent.

2. The stent of claim 1 wherein the stent has a composite expanded percentage open area of approximately 70%.

3. The stent of claim 1 wherein the stent has a composite expanded percentage open area of approximately 75%.

4. The stent of claim 1 wherein the stent has a composite expanded percentage open area of approximately 80%.

5. The stent of claim 1 wherein the stent has a composite expanded percentage open area of approximately 85%.

6. The stent of claim 1 wherein the stent has a composite expanded percentage open area of approximately 90%.

7. The stent of claim 1 , wherein the barrier portion consists of metal.

Assignments (5)
MERGER Recorded Nov 5, 2014
From: EV3 PERIPHERAL, INC.
To: EV3 INC.
Reel/Frame 034110/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2014
From: EV3 LLC
To: TYCO HEALTHCARE GROUP, LP
Reel/Frame 034110/0405 →
CHANGE OF NAME Recorded Nov 5, 2014
From: TYCO HEALTHCARE GROUP, LP
To: COVIDIEN LP
Reel/Frame 034174/0083 →
CHANGE OF NAME Recorded Nov 5, 2014
From: EV3 INC.
To: EV3 LLC
Reel/Frame 034174/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2008
From: MA, JIANLU; MOLLAND, DOUGLAS; TATALOVICH, JOE; VOGEL, JEFF; DUDNEY, JOSH; VANDLIK, MARK; KUSLEIKA, RICHARD
To: EV3 PERIPHERAL, INC.
Reel/Frame 020601/0972 →
Continuity (2)
Provisional Application 60866311 · Nov 17, 2006
Related Publication 20080167708A1 · Jul 10, 2008